Avista Therapeutics
PrivateLast Round
Seed
Jul 19, 2022
Total Funding Raised
$10M
Company Overview
Avista Therapeutics operates in Healthcare & Life Sciences and is based in Pittsburgh, Pennsylvania. Its latest recorded funding round was a Seed round in July 2022.
Avista Therapeutics is a biotechnology company that develops gene therapies for retinal diseases and other ophthalmic conditions using its proprietary AI-driven AAV capsid engineering platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Avista Therapeutics Comparables
Compare Avista Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Capsida Biotherapeutics | 89% | |
| Latus Bio | 87% | |
| Dyno Therapeutics | 81% |
For institutional investors. Book with your work email.
Avista Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Avista Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| UPMC Enterprises | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 2, 2026
Grew 16% QoQ, from 19 to 22 employees.
- Nov 7, 2025
Monthly visitors grew 296% MoM, from 393 to 1.6K.
For institutional investors. Book with your work email.
Avista Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Avista Therapeutics's valuation, stock price, and market status.
Is Avista Therapeutics a public or private company?
Avista Therapeutics is a private company.
What is the current stock price of Avista Therapeutics?
Avista Therapeutics is a private company, so its shares have no public market price. Caplight tracks Avista Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Avista Therapeutics worth (valuation)?
Valuation information for Avista Therapeutics is not publicly available.
Can I buy Avista Therapeutics stock?
Avista Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Avista Therapeutics's last funding round?
Avista Therapeutics's most recent funding round was Seed on July 19, 2022.
Who are the main investors in Avista Therapeutics?
Key investors in Avista Therapeutics include UPMC Enterprises.
Will Avista Therapeutics IPO soon?
No public IPO plans have been announced for Avista Therapeutics.
How can I track Avista Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Avista Therapeutics's shares on secondary markets.